Matches in SemOpenAlex for { <https://semopenalex.org/work/W4250493726> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4250493726 abstract "The discovery of cannabinoid receptors and endocannabinoid system has led to the potential therapeutic use of cannabis derivatives. Cannabinoids acting through the CB1 receptors modulate the release of other neurotransmitters in central nervous system, whereas the activation of peripheral CB2 receptors results in decreased inflammatory response and increased apoptosis of some tumor cells populations. The cannabinoids have been authorized for chemotherapy-induced nausea and vomiting; stimulation of appetite; to alleviate neuropathic pain and spasticity in multiple sclerosis, and to reduce pain in cancer patients. Efficacy in other diseases and clinical conditions should be proven in ongoing or future clinical trials. Isolation and identification of different cannabinoids from cannabis and synthesis of novel, more selective, derivatives widens their therapeutic potential. However, there are numerous adverse effects reported, especially when cannabinoids formulations with unknown quantitative and qualitative composition are used. Addiction, tolerance, withdrawal symptoms, increased risk of acute myocardial re-infarction, and increased risk of psychosis or worsening of psychosis are the most common adverse effects of cannabinoids. Acute adverse effects e. g. severe central nervous system depression, are more pronounced in children than in adults. Potential cannabinoid medicines should be subject to the same regulations as other potential drugs. Safety and efficacy of any potential drug candidate, regardless whether it is plant-derived or synthesized, should be proven in non-clinical studies and clinical trials, as well as the marketing authorization must be issued by the appropriate drug authority. Patients deserve a quality manufactured product, which always contains the specified amount of Remedium cardinale." @default.
- W4250493726 created "2022-05-12" @default.
- W4250493726 creator A5038675241 @default.
- W4250493726 creator A5040924693 @default.
- W4250493726 creator A5062632796 @default.
- W4250493726 creator A5068820951 @default.
- W4250493726 creator A5081063219 @default.
- W4250493726 creator A5088854169 @default.
- W4250493726 date "2015-06-29" @default.
- W4250493726 modified "2023-10-17" @default.
- W4250493726 title "FARMAKOLOGIJA KANABINOIDOV" @default.
- W4250493726 doi "https://doi.org/10.6016/zdravvestn.1360" @default.
- W4250493726 hasPublicationYear "2015" @default.
- W4250493726 type Work @default.
- W4250493726 citedByCount "1" @default.
- W4250493726 countsByYear W42504937262021 @default.
- W4250493726 crossrefType "journal-article" @default.
- W4250493726 hasAuthorship W4250493726A5038675241 @default.
- W4250493726 hasAuthorship W4250493726A5040924693 @default.
- W4250493726 hasAuthorship W4250493726A5062632796 @default.
- W4250493726 hasAuthorship W4250493726A5068820951 @default.
- W4250493726 hasAuthorship W4250493726A5081063219 @default.
- W4250493726 hasAuthorship W4250493726A5088854169 @default.
- W4250493726 hasBestOaLocation W42504937261 @default.
- W4250493726 hasConcept C118552586 @default.
- W4250493726 hasConcept C126322002 @default.
- W4250493726 hasConcept C148001335 @default.
- W4250493726 hasConcept C170493617 @default.
- W4250493726 hasConcept C197934379 @default.
- W4250493726 hasConcept C2776895053 @default.
- W4250493726 hasConcept C2777056318 @default.
- W4250493726 hasConcept C2777846614 @default.
- W4250493726 hasConcept C2778938600 @default.
- W4250493726 hasConcept C2779727114 @default.
- W4250493726 hasConcept C2780580376 @default.
- W4250493726 hasConcept C2780871563 @default.
- W4250493726 hasConcept C46721173 @default.
- W4250493726 hasConcept C535046627 @default.
- W4250493726 hasConcept C71924100 @default.
- W4250493726 hasConcept C98274493 @default.
- W4250493726 hasConceptScore W4250493726C118552586 @default.
- W4250493726 hasConceptScore W4250493726C126322002 @default.
- W4250493726 hasConceptScore W4250493726C148001335 @default.
- W4250493726 hasConceptScore W4250493726C170493617 @default.
- W4250493726 hasConceptScore W4250493726C197934379 @default.
- W4250493726 hasConceptScore W4250493726C2776895053 @default.
- W4250493726 hasConceptScore W4250493726C2777056318 @default.
- W4250493726 hasConceptScore W4250493726C2777846614 @default.
- W4250493726 hasConceptScore W4250493726C2778938600 @default.
- W4250493726 hasConceptScore W4250493726C2779727114 @default.
- W4250493726 hasConceptScore W4250493726C2780580376 @default.
- W4250493726 hasConceptScore W4250493726C2780871563 @default.
- W4250493726 hasConceptScore W4250493726C46721173 @default.
- W4250493726 hasConceptScore W4250493726C535046627 @default.
- W4250493726 hasConceptScore W4250493726C71924100 @default.
- W4250493726 hasConceptScore W4250493726C98274493 @default.
- W4250493726 hasIssue "6" @default.
- W4250493726 hasLocation W42504937261 @default.
- W4250493726 hasOpenAccess W4250493726 @default.
- W4250493726 hasPrimaryLocation W42504937261 @default.
- W4250493726 hasRelatedWork W1989418801 @default.
- W4250493726 hasRelatedWork W2032506781 @default.
- W4250493726 hasRelatedWork W2329963239 @default.
- W4250493726 hasRelatedWork W2733861452 @default.
- W4250493726 hasRelatedWork W2794660688 @default.
- W4250493726 hasRelatedWork W2909195752 @default.
- W4250493726 hasRelatedWork W2985680547 @default.
- W4250493726 hasRelatedWork W3007111147 @default.
- W4250493726 hasRelatedWork W3118775926 @default.
- W4250493726 hasRelatedWork W32588219 @default.
- W4250493726 hasVolume "84" @default.
- W4250493726 isParatext "false" @default.
- W4250493726 isRetracted "false" @default.
- W4250493726 workType "article" @default.